Read the full article at PR Newswire: Clinical Trials & Medical Discoveries
General
ThromboGenics to Present Results of Second Phase III Trial of Microplasmin at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress
Read the full article at PR Newswire: Clinical Trials & Medical Discoveries
